Jin Wei Kou
Finanzdirektor/CFO bei Universal Bespoke Condiment Co., Ltd.
Aktive Positionen von Jin Wei Kou
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Universal Bespoke Condiment Co., Ltd.
Universal Bespoke Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Universal Bespoke Condiment Co., Ltd. is an investment holding company. It is involved in research and development, manufacturing and sale of compound condiment and extracts products. The company was founded on August 23, 2016 and is headquartered in Hong Kong. | Finanzdirektor/CFO | 21.07.2017 | - |
Karriereverlauf von Jin Wei Kou
Ehemalige bekannte Positionen von Jin Wei Kou
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Salion Food Condiment Co., Ltd.
Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China. | Finanzdirektor/CFO | 21.07.2017 | 01.01.2018 |
Marcum Asia CPAs LLP
Marcum Asia CPAs LLP Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Marcum Asia CPAs LLP provides public accounting services. The company is based in Beijing, China. The CEO of the Chinese company is Enze Liang. | Vorstandsvorsitzender | 01.01.2008 | 01.01.2016 |
Deloitte Touche Tohmatsu CPA Ltd.
Deloitte Touche Tohmatsu CPA Ltd. Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu CPA Ltd. is a Chinese company that provides accounting, tax, audit, and assurance services. The company is based in Shanghai, China. The company was founded in 1993. | Corporate Officer/Principal | 01.07.2005 | 01.04.2008 |
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Comptroller/Controller/Auditor | 16.09.2019 | - |
Finanzdirektor/CFO | 16.09.2019 | - |
Ausbildung von Jin Wei Kou
Peking University | Undergraduate Degree |
Statistik
International
China | 6 |
Vereinigte Staaten | 2 |
Operativ
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sektoral
Consumer Non-Durables | 3 |
Commercial Services | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Universal Bespoke Condiment Co., Ltd.
Universal Bespoke Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Universal Bespoke Condiment Co., Ltd. is an investment holding company. It is involved in research and development, manufacturing and sale of compound condiment and extracts products. The company was founded on August 23, 2016 and is headquartered in Hong Kong. | Consumer Non-Durables |
Deloitte Touche Tohmatsu CPA Ltd.
Deloitte Touche Tohmatsu CPA Ltd. Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu CPA Ltd. is a Chinese company that provides accounting, tax, audit, and assurance services. The company is based in Shanghai, China. The company was founded in 1993. | Commercial Services |
Marcum Asia CPAs LLP
Marcum Asia CPAs LLP Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Marcum Asia CPAs LLP provides public accounting services. The company is based in Beijing, China. The CEO of the Chinese company is Enze Liang. | Commercial Services |
Salion Food Condiment Co., Ltd.
Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China. | Consumer Non-Durables |
Xynomic Pharmaceuticals Holdings, Inc.
Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China. | Health Technology |
- Börse
- Insiders
- Jin Wei Kou
- Erfahrung